SurgiSteer laparoscopic instruments released in the US

Steerable Technologix LLC announces the US release of its SurgiSteer™ laparoscopic instruments.  Developed from licensed technology from OrthoDynamix LLC, the SurgiSteer product line will exploit single port laparoscopic surgery with its steerable 5mm instrumentation. The Lap Grasper, Maryland Dissector and Endo Scissors, available in both free and ratchet handle configurations are simplistic in use versus competitive devices.  "Our design mission was to offer the most robust steerable laparoscopic instrument in the market while offering the surgeon a user friendly product with limited transitional barriers," said Bill Dennis, CEO.  "Our devices exhibit many steerable features that heretofore haven't been available to the surgeon such as high force opening jaws for blunt tissue dissection, strong jaw closing force for reliably driving suture needles, and a very intuitive bend and locking mechanism which eliminates excessive hand motion.  The SurgiSteer product portfolio will increase throughout the year to include RF devices," says Dennis.

Steerable instruments are necessary in one port surgery so as to create the proper orientation and/or triangulation for the surgeon while working through the umbilicus.

Source:

Steerable Technologix LLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered MRI predicts outcomes in prostate cancer